Nationwide registry for catheter ablation treatment of cardiac arrhythmias in Japan
Japanese Catheter Ablation Registry
This study is collecting information on how well catheter ablation works for treating heart rhythm problems in Japan to see how safe and effective the procedure is.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400000 (estimated) |
| Sex | All |
| Sponsor | National Cerebral and Cardiovascular Center, Japan Academic / other |
| Locations | 1 site (Suita, Osaka) |
| Trial ID | NCT03729232 on ClinicalTrials.gov |
What this trial studies
The Japanese Catheter Ablation Registry is a voluntary nationwide observational registry aimed at collecting and analyzing data on catheter ablation treatments for cardiac arrhythmias across Japan. Conducted by the Japanese Heart Rhythm Society in collaboration with the National Cerebral and Cardiovascular Center, this registry utilizes a Research Electronic Data Capture (REDCap) system for prospective data collection. It focuses on documenting the acute success rates, complications, and various predictive factors associated with catheter ablation procedures. Data is collected annually, providing valuable insights into the effectiveness and safety of these treatments in Japanese arrhythmia units.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients in Japan who are undergoing catheter ablation for cardiac arrhythmias.
Not a fit: Patients who refuse to consent to participate in the registry will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of catheter ablation outcomes and improve treatment protocols for patients with cardiac arrhythmias.
How similar studies have performed: Other observational registries have shown success in improving treatment outcomes and understanding complications in similar medical fields.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients treated with catheter ablation in Japan Exclusion Criteria: * Patients who refused to consent
Where this trial is running
Suita, Osaka
- National Cerebral and Cardiovascular Center — Suita, Osaka, Japan (Recruiting)
Study contacts
- Principal investigator: Teiichi Yamane, MD, PhD — The Jikei University School of Medicine
- Study coordinator: Kengo Kusano, MD, PhD
- Email: kusanokengo@ncvc.go.jp
- Phone: +81-6-6170-1070
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.